Cargando…

The new tactiflex ablation catheter: reducing the time for radiofrequency atrial fibrillation ablation

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public hospital(s). Main funding source(s): Azienda Ospedaliero-Univerisitaria delle Marche BACKGROUND: Pulmonary vein isolation (PVI) by radiofrequency (RF) ablation is a well-established and effective treatment for paroxysmal and persistent atrial...

Descripción completa

Detalles Bibliográficos
Autores principales: D Angelo, L, Parisi, Q P, Compagnucci, P C, Volpato, G V, Rita, E R, Centanni, M C, Molini, S M, Cipolletta, L C, Valeri, Y V, Luciani, L L, Gaggiotti, G G, Guerra, F G, Casella, M S, Natale, A N, Dello Russo, A D R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207618/
http://dx.doi.org/10.1093/europace/euad122.742
_version_ 1785046497418543104
author D Angelo, L
Parisi, Q P
Compagnucci, P C
Volpato, G V
Rita, E R
Centanni, M C
Molini, S M
Cipolletta, L C
Valeri, Y V
Luciani, L L
Gaggiotti, G G
Guerra, F G
Casella, M S
Natale, A N
Dello Russo, A D R
author_facet D Angelo, L
Parisi, Q P
Compagnucci, P C
Volpato, G V
Rita, E R
Centanni, M C
Molini, S M
Cipolletta, L C
Valeri, Y V
Luciani, L L
Gaggiotti, G G
Guerra, F G
Casella, M S
Natale, A N
Dello Russo, A D R
author_sort D Angelo, L
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public hospital(s). Main funding source(s): Azienda Ospedaliero-Univerisitaria delle Marche BACKGROUND: Pulmonary vein isolation (PVI) by radiofrequency (RF) ablation is a well-established and effective treatment for paroxysmal and persistent atrial fibrillation (AF). Compared to low-power-long-duration (LPLD) RF ablation, the high-power-short duration (HPSD) one produces shallower lesions reducing potential adverse effects, without affecting efficacy. The new TactiFlex Ablation Catheter, Sensor Enabled (TFSE), combining a flexible tip with fiber optic-based contact force sensing, can deliver HSPD RF, obtaining a faster PVI. OBJECTIVE: To test feasibility, safety, and effectiveness of RF AF ablation performed by TFSE, comparing it with LPLD RF AF ablation using TactiCath Contact Force Ablation catheter, Sensor Enabled (TCSE). METHODS: We conducted a prospective study including 50 consecutive patients admitted to our centre for paroxysmal or persistent AF catheter ablation. The patients were randomly divided into 2 groups according to ablation protocol: 25 patients were treated with HPSD performed by TFSE [63 (53-68) years, male 19]; 25 patients were treated with LPLD by TCSE [62 (51-69); male 12). In the HPSD group, the lesions were performed delivering 50W up to 10 seconds with a contact force (CF) index ranging from 5g to 20g. In the LPLD group, the lesions were performed delivering 40W in the anterior segments of veins (LSI 5-5.5) and 35W in the posterior segments (LSI 4-4.5). RESULTS: PVI was achieved in 100% of patients in both groups. No periprocedural complication was reported. No statistically significant differences were found in terms of clinical and echocardiographic characteristics. A significant decrease in PVI time was reported in TFSE group for every pulmonary vein (LSPV: 2.14±0.13 min vs 10.63±5.34, p<0.005; LIPV 2.10±0.12 min vs 10.50±5.56 min, p<0.005; RSPV: 2.20±0.14 min vs 10±6.35 min, p<0.005; RIPV 3.10±5.21 min vs 10.40±8.54 min, p<0.005). No difference was reported for the impendence drop (17 Ω, range 15.3-18 in TFSE vs 15 Ω, range 14.5-17.5 in TCSE, p=0.114). A shorter total procedural time (110 min, range 90-121 vs 155 min, range 128-190, p<0.005) and LA mapping time (8 min, range 6-10 vs 13 min, range 11-14, p<0.005) were reported in TFSE group, while no difference was reported in total fluoroscopy time (16 min, range 12-19.30 vs 19 min, range 14-27, p=0,062). The RF total time was superior in the TCSE group. CONCLUSIONS: In our initial experience, TactiFlex catheter allows a safe, effective and faster PVI in patients affected by paroxysmal and persistent AF undergoing RF ablation. The shorter time for PVI is the main contributor for shortening total procedural times. However, our results have to be confirmed in larger studies. [Figure: see text]
format Online
Article
Text
id pubmed-10207618
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102076182023-05-25 The new tactiflex ablation catheter: reducing the time for radiofrequency atrial fibrillation ablation D Angelo, L Parisi, Q P Compagnucci, P C Volpato, G V Rita, E R Centanni, M C Molini, S M Cipolletta, L C Valeri, Y V Luciani, L L Gaggiotti, G G Guerra, F G Casella, M S Natale, A N Dello Russo, A D R Europace 9.4.4 - Catheter Ablation of Arrhythmias FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public hospital(s). Main funding source(s): Azienda Ospedaliero-Univerisitaria delle Marche BACKGROUND: Pulmonary vein isolation (PVI) by radiofrequency (RF) ablation is a well-established and effective treatment for paroxysmal and persistent atrial fibrillation (AF). Compared to low-power-long-duration (LPLD) RF ablation, the high-power-short duration (HPSD) one produces shallower lesions reducing potential adverse effects, without affecting efficacy. The new TactiFlex Ablation Catheter, Sensor Enabled (TFSE), combining a flexible tip with fiber optic-based contact force sensing, can deliver HSPD RF, obtaining a faster PVI. OBJECTIVE: To test feasibility, safety, and effectiveness of RF AF ablation performed by TFSE, comparing it with LPLD RF AF ablation using TactiCath Contact Force Ablation catheter, Sensor Enabled (TCSE). METHODS: We conducted a prospective study including 50 consecutive patients admitted to our centre for paroxysmal or persistent AF catheter ablation. The patients were randomly divided into 2 groups according to ablation protocol: 25 patients were treated with HPSD performed by TFSE [63 (53-68) years, male 19]; 25 patients were treated with LPLD by TCSE [62 (51-69); male 12). In the HPSD group, the lesions were performed delivering 50W up to 10 seconds with a contact force (CF) index ranging from 5g to 20g. In the LPLD group, the lesions were performed delivering 40W in the anterior segments of veins (LSI 5-5.5) and 35W in the posterior segments (LSI 4-4.5). RESULTS: PVI was achieved in 100% of patients in both groups. No periprocedural complication was reported. No statistically significant differences were found in terms of clinical and echocardiographic characteristics. A significant decrease in PVI time was reported in TFSE group for every pulmonary vein (LSPV: 2.14±0.13 min vs 10.63±5.34, p<0.005; LIPV 2.10±0.12 min vs 10.50±5.56 min, p<0.005; RSPV: 2.20±0.14 min vs 10±6.35 min, p<0.005; RIPV 3.10±5.21 min vs 10.40±8.54 min, p<0.005). No difference was reported for the impendence drop (17 Ω, range 15.3-18 in TFSE vs 15 Ω, range 14.5-17.5 in TCSE, p=0.114). A shorter total procedural time (110 min, range 90-121 vs 155 min, range 128-190, p<0.005) and LA mapping time (8 min, range 6-10 vs 13 min, range 11-14, p<0.005) were reported in TFSE group, while no difference was reported in total fluoroscopy time (16 min, range 12-19.30 vs 19 min, range 14-27, p=0,062). The RF total time was superior in the TCSE group. CONCLUSIONS: In our initial experience, TactiFlex catheter allows a safe, effective and faster PVI in patients affected by paroxysmal and persistent AF undergoing RF ablation. The shorter time for PVI is the main contributor for shortening total procedural times. However, our results have to be confirmed in larger studies. [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10207618/ http://dx.doi.org/10.1093/europace/euad122.742 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 9.4.4 - Catheter Ablation of Arrhythmias
D Angelo, L
Parisi, Q P
Compagnucci, P C
Volpato, G V
Rita, E R
Centanni, M C
Molini, S M
Cipolletta, L C
Valeri, Y V
Luciani, L L
Gaggiotti, G G
Guerra, F G
Casella, M S
Natale, A N
Dello Russo, A D R
The new tactiflex ablation catheter: reducing the time for radiofrequency atrial fibrillation ablation
title The new tactiflex ablation catheter: reducing the time for radiofrequency atrial fibrillation ablation
title_full The new tactiflex ablation catheter: reducing the time for radiofrequency atrial fibrillation ablation
title_fullStr The new tactiflex ablation catheter: reducing the time for radiofrequency atrial fibrillation ablation
title_full_unstemmed The new tactiflex ablation catheter: reducing the time for radiofrequency atrial fibrillation ablation
title_short The new tactiflex ablation catheter: reducing the time for radiofrequency atrial fibrillation ablation
title_sort new tactiflex ablation catheter: reducing the time for radiofrequency atrial fibrillation ablation
topic 9.4.4 - Catheter Ablation of Arrhythmias
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207618/
http://dx.doi.org/10.1093/europace/euad122.742
work_keys_str_mv AT dangelol thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT parisiqp thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT compagnuccipc thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT volpatogv thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT ritaer thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT centannimc thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT molinism thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT cipollettalc thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT valeriyv thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT lucianill thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT gaggiottigg thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT guerrafg thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT casellams thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT natalean thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT dellorussoadr thenewtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT dangelol newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT parisiqp newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT compagnuccipc newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT volpatogv newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT ritaer newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT centannimc newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT molinism newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT cipollettalc newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT valeriyv newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT lucianill newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT gaggiottigg newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT guerrafg newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT casellams newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT natalean newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation
AT dellorussoadr newtactiflexablationcatheterreducingthetimeforradiofrequencyatrialfibrillationablation